Effects of Nasal CPAP Treatment on Insulin Resistance, Lipid Profile, and Plasma Leptin in Sleep Apnea
- Çağlar ÇuhadaroğluAffiliated withDepartment of Chest Diseases, Istanbul Faculty of Medicine, Istanbul University Email author
- , Ayfer UtkusavaşAffiliated withDepartment of Chest Diseases, Istanbul Faculty of Medicine, Istanbul University
- , Levent ÖztürkAffiliated withDepartment of Physiology, Trakya University Faculty of Medicine
- , Serpil SalmanAffiliated withDepartment of Endocrinology, Istanbul Faculty of Medicine, Istanbul University
- , Turhan EceAffiliated withDepartment of Chest Diseases, Istanbul Faculty of Medicine, Istanbul University
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Obstructive sleep apnea has been linked with metabolic syndrome characterized by dyslipidemia, dyscoagulation, hypertension, and diabetes mellitus type 2 and their cardiovascular consequences. This study was designed to determine the effects of 8 weeks of therapy with continuous positive airway pressure (CPAP) on insulin resistance, glucose, and lipid profile, and the relationship between leptin and insulin-resistance parameters in patients with moderate-to-severe obstructive sleep apnea.
In 44 patients, serum cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein, very low-density lipoprotein, leptin, and insulin parameters were measured at baseline and after 8 weeks of CPAP. Insulin resistance index was based on the homeostasis model assessment (HOMA-IR) method. Insulin sensitivity (HOMA-S) and insulin secretion capacity (HOMA-β) also were calculated. Thirteen patients were excluded from statistical analyses due to noncompliant CPAP usage (<4 h night−1).
In 31 patients who used CPAP for ≥4 h night−1, CPAP therapy reduced total cholesterol (P < 0.05), low-density lipoprotein (P < 0.05), and leptin (P < 0.05). Circulating leptin levels showed significant correlation with both HOMA-S and HOMA-IR at baseline and follow-up (P = 0.03 for all). In addition, there was no correlation between HOMA-IR and the severity of sleep apnea, which was shown by apnea-hypopnea index.
In patients with moderate-to-severe obstructive sleep apnea, compliant CPAP usage may improve insulin secretion capacity, reduce leptin, total cholesterol, and low-density lipoprotein levels. Leptin showed significant relationship with insulin resistance, and this relationship remained after 8 weeks of CPAP therapy.
KeywordsSleep apnea Leptin Insulin resistance Continuous positive airway pressure Lipid
- Effects of Nasal CPAP Treatment on Insulin Resistance, Lipid Profile, and Plasma Leptin in Sleep Apnea
Volume 187, Issue 2 , pp 75-81
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Sleep apnea
- Insulin resistance
- Continuous positive airway pressure
- Industry Sectors
- Author Affiliations
- 1. Department of Chest Diseases, Istanbul Faculty of Medicine, Istanbul University, Göğüs Hastalıkları Anabilim Dalı, Istanbul, Turkey
- 2. Department of Physiology, Trakya University Faculty of Medicine, Edirne, Turkey
- 3. Department of Endocrinology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey